Navigation Links
Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy
Date:8/1/2014

Hobby, president of Families of SMA.  "SMA is a devastating disease with no current therapeutic options.  Families of SMA applauds Isis for progressing its development program in an expedient manner, and looks forward to additional trials in patients with SMA beginning later in 2014."

ENDEAR, a Phase 3 study of ISIS-SMNRx, is a randomized, double-blind, sham-procedure controlled thirteen month study in approximately 110 infants diagnosed with SMA.  The study will evaluate the efficacy and safety of a 12 mg dose of ISIS-SMNRx with a primary endpoint of survival or permanent ventilation.  Additional efficacy endpoints are also included in the study.  For further study information, please visit www.clinicaltrials.gov and search for ISIS-SMNRx or the identifier number NCT02193074 or visit the ISIS-SMNRx study site at www.smastudy.com

ABOUT ISIS-SMNRx
ISIS-SMNRx is designed to alter the splicing of a closely related gene (SMN2) to increase production of fully functional SMN protein.  The United States Food and Drug Administration granted orphan drug status and fast track designation to ISIS-SMNRx for the treatment of patients with SMA.  Isis is currently in collaboration with Biogen Idec to develop and potentially commercialize the investigational compound, ISIS-SMNRx, to treat all types of SMA.  Under the terms of the January 2012 agreement, Isis is responsible for global development and Biogen Idec has the option to license the compound until completion of the first successful Phase 2/3 study or the completion of two Phase 2/3 studies. 

Isis acknowledges support from the following organizations for ISIS-SMNRx: Muscular Dystrophy Association, SMA Foundation, Families of SMA and intellectual property licen
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014
2. Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results
3. Auxilium Pharmaceuticals, Inc. To Announce Second Quarter 2014 Results On August 7, 2014
4. Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs
5. Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results
6. Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytrens Contracture In Japan
7. Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity
8. Access Pharmaceuticals Featured On OncLive.com
9. Immune Pharmaceuticals Commences Patient Screening For Bertilimumab Phase II Clinical Trial In Bullous Pemphigoid, A Rare Auto-Immune Disease Of The Skin
10. Alexza Pharmaceuticals Announces Participation in Upcoming Investor Conferences
11. Cloud Pharmaceuticals Receives Phase I NSF SBIR Grant Valued at $150,000
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... MELVILLE, N.Y. , Nov. 21, 2014  Cardinal ... the world,s largest health care services companies, and Henry ... largest provider of health care products and services to ... that the companies have entered into a long-term strategic ... and product offerings to office-based medical practices.  This strategic ...
(Date:11/21/2014)... 20, 2014  RedRick Technologies, a provider of ... room environment guidance, has helped the new Penn ... room, which may also serve as a model ... "In line with the tenets ... Radiology,s Imaging 3.0 ™ initiative, the new ...
(Date:11/21/2014)... , Nov. 20, 2014 Depomed, Inc. (NASDAQ: ... the Piper Jaffray 26 th Annual Healthcare Conference in ... the Piper Jaffray conference is scheduled for 8:00 am EST (5:00 ... webcast, and the webcast can be accessed via the Investor Relations ... of the webcast will be archived for 30 days on the ...
Breaking Medicine Technology:Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 2Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 3Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 4Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 5RedRick Technologies Helps Penn Radiology Implement New Radiology Reading Room Concepts 2RedRick Technologies Helps Penn Radiology Implement New Radiology Reading Room Concepts 3Depomed To Present At Piper Jaffray 26th Annual Healthcare Conference 2
(Date:11/22/2014)... AZ (PRWEB) November 22, 2014 Hastings ... with decades of experience announces providing clients with the ... The firm offers clients a flexible, intuitive and easy ... combined with having access to Google + allows clients ... order to make a more informed decision when retaining ...
(Date:11/22/2014)... Petersburg, FL (PRWEB) November 22, 2014 ... Kitchen Innovations are pleased to announce that Ashley ... the Thanksgiving #PayItForward contest. , Ms. Lombardo entered ... from Kitchen Innovations. She wrote of how her friend ... young daughters as a single mom. Despite medical bills ...
(Date:11/22/2014)... 2014 Sandbridge Capital, a private ... the consumer brand sector, acquired a minority stake ... used to help fund BackJoy’s global growth and ... its proprietary apparel and footwear lines. Sandbridge Capital ... of Directors. , BackJoy is a high-growth health ...
(Date:11/22/2014)... Viejo, California (PRWEB) November 22, 2014 Developers ... announced a new plugin entitled FCPX 3D Model bringing the ... “FCPX 3D Model allows users to add obj files to ... Pixel Film Studios. “Blurring the line between professional and armature, ... Model from Pixel Film Studios allows Final Cut Pro X ...
(Date:11/22/2014)... (PRWEB) November 22, 2014 Wright & ... AndroGel side-effects lawsuits have been scheduled between October ... Northern District of Illinois. U.S. District Judge Matthew F. ... a Case Management Order (CMO) on November 6, 2014 ... for attorneys to submit documents and other activities in ...
Breaking Medicine News(10 mins):Health News:Hastings and Hastings Announces Providing Clients with the Option of Leaving an Online Review Using Google + 2Health News:Hastings and Hastings Announces Providing Clients with the Option of Leaving an Online Review Using Google + 3Health News:Forbes Living TV Announces Winner of Thanksgiving #PayItForward Contest 2Health News:Sandbridge Capital Acquires a Minority Stake in BackJoy 2Health News:Sandbridge Capital Acquires a Minority Stake in BackJoy 3Health News:Pixel Film Studios released FCPX 3D Model plugin Exclusively for Final Cut Pro X 2Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 2Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 3Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 4
... the University of Copenhagen have collaborated with the company ... of the brain,s complex communication system. The discovery could ... for patients with psychiatric disorders. The results were recently ... to the puzzle of brain functionNew knowledge challenges established ...
... (HealthDay News) -- A calcium test performed with the assistance ... likelihood that certain patients at moderate risk of heart problems ... The test to detect coronary calcium can help physicians ... their cardiovascular risks, the study authors explained. At ...
... Albany, NY (August 18, 2011) AMRI (NASDAQ: ... award from the National Institutes of Health (NIH)/National ... provide chemistry and other drug discovery technologies in ... (MCNP), part of the NIH Blueprint Neurotherapeutics Network. ...
... Reporter , THURSDAY, Aug. 18 (HealthDay News) -- The 2011-12 ... last year,s, but that doesn,t mean it,s OK to skip ... Disease Control and Prevention warn. "All people aged ... Bridges, an associate director for adult immunization at the CDC,s ...
... , THURSDAY, Aug. 18 (HealthDay News) -- Flu vaccination ... recent years but are still below the 2020 national ... the U.S. Centers for Disease Control and Prevention also ... All health care personnel should get an annual ...
... they are more like complex societies, each with a ... Understanding this "social structure" of tumors is critical for ... may be sensitive to different drugs. A common theory ... all cancer cells descend from special self-renewing cancer stem ...
Cached Medicine News:Health News:New piece to the puzzle of brain function 2Health News:Test for Calcium Buildup May Spot Heart Attack, Stroke Risk 2Health News:AMRI receives NIH contract award for development of pre-clinical drug candidates 2Health News:Don't Skip This Year's Flu Shot: CDC 2Health News:Flu Shot Rates Low for Health Workers, Moms-to-Be: CDC 2Health News:Cancer stem cells made, not born 2Health News:Cancer stem cells made, not born 3
Interchangeable design allows you to select a single handpiece and change tips during the procedure. Universal connector. Disassembles for easy cleaning. Tips can rotate 360 degrees to re-orient port...
Interchangeable design allows you to select a single handpiece and change tips during the procedure. Universal connector. Disassembles for easy cleaning. Tips can rotate 360 degrees to re-orient port...
Infusion Cannula, 4.0mm....
Subretinal Injection Cannula, Straight; 20g (0.90) x 1" (25mm); Tip Extension: 3mm, 32g (0.23); Angled at 35°....
Medicine Products: